"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
| Descriptor ID |
D009367
|
| MeSH Number(s) |
E01.789.625
|
| Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 4 | 5 |
| 2001 | 2 | 5 | 7 |
| 2002 | 0 | 7 | 7 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 9 | 9 |
| 2005 | 2 | 10 | 12 |
| 2006 | 0 | 12 | 12 |
| 2007 | 0 | 16 | 16 |
| 2008 | 1 | 17 | 18 |
| 2009 | 4 | 15 | 19 |
| 2010 | 0 | 14 | 14 |
| 2011 | 0 | 21 | 21 |
| 2012 | 0 | 13 | 13 |
| 2013 | 1 | 21 | 22 |
| 2014 | 0 | 23 | 23 |
| 2015 | 0 | 19 | 19 |
| 2016 | 2 | 23 | 25 |
| 2017 | 0 | 21 | 21 |
| 2018 | 0 | 15 | 15 |
| 2019 | 2 | 11 | 13 |
| 2020 | 1 | 16 | 17 |
| 2021 | 0 | 15 | 15 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes. Clin Lymphoma Myeloma Leuk. 2024 Dec; 24(12):837-842.
-
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ? 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. J Clin Oncol. 2024 Sep 01; 42(25):3012-3021.
-
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study. Gynecol Oncol. 2024 06; 185:202-211.
-
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates. JCO Precis Oncol. 2024 Jun; 8:e2300362.
-
Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70?years and over. Gynecol Oncol. 2024 08; 187:221-226.
-
Success Rates of Sentinel Lymph Node Mapping for Endometrial Cancer in Patients with Body Mass Index < 45 Compared with Body Mass Index = 45. J Minim Invasive Gynecol. 2023 09; 30(9):735-741.
-
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. JAMA Netw Open. 2023 04 03; 6(4):e238437.
-
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy. J Clin Oncol. 2023 06 01; 41(16):3009-3018.
-
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort. J Urol. 2023 05; 209(5):882-889.
-
Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. J Surg Res. 2023 04; 284:42-53.